Cigna Corporation (CI) EVP, CHRO Owns Stock Worth $3009.0

BEPC Stock
BEPC Stock

Cigna Corporation (NYSE:CI) finished Friday with an addition of $0.62 to close at $331.34, an upside of 0.19 percent. An average of 603,800 shares of common stock have been traded in the last five days. There was a fall of -$1.94 in the past week, and it reached a new high 54 times over the past 12 months. The last 20 days have seen an average of 1,279,940 shares traded, while the 50-day average volume stands at 1,715,716.

CI stock has increased by 0.74% in the last month. The company shares reached their 1-month lowest point of $321.60 on 12/16/22. With the stock rallying to its 52-week high on 12/13/22, shares of the company touched a low of $213.16 and a high of $340.11 in 52 weeks. It has reached a new high 53 times so far this year and achieved 44.29% or $101.71 in price. In spite of this, the price is down -2.58% from the 52-week high.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…


Insider Transactions

CI stock investors should be aware that Cigna Corporation (CI) stock had its last reported insider trading activity 15 days ago on Dec 16. In this transaction, the insider spent $986,802. Pres., International Markets, Sadler Jason D, disposed of 16,667 shares at a price of $333.88 on Dec 08. The insider now owns more than $5,564,763 worth of shares. Prior to that, President & CEO, Evernorth Palmer Eric P went on to Sale 4,000 shares at $300.00 each on Oct 14. An amount of $1,200,004 was transacted.

Valuation Metrics

Cigna Corporation (CI) has a trailing price-to-earnings (P/E) ratio of 15.83. The stock’s beta is 0.69. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 0.56, the price-to-book (PB) ratio at 2.24, and the price-to-cash flow ratio at 12.31.

The company has a payout ratio of 20.60%. The company’s most recent quarterly dividend payment was $1.12 a share, without any change from last year. Its latest increase dividend $0.12 reported on Thursday February 3 2022.

Financial Health

Further, the company has a long term debt to equity ratio of 0.62 and a total debt to equity ratio of 0.70 for the quarter ending September 29. Its gross profit as reported stood at $6.78 billion compared to revenue of $174.08 billion.

Earnings Surprise

For the three-month period that ended September 29, Cigna Corporation had $28.09 billion in total debt. In the quarter under review, the net income was down than the previous quarter. The company posted a net income of $2.76 billion in the quarter, while revenues of $1.56 billion were grew 41.2%. The analyst consensus anticipated Cigna Corporation’s latest quarter earnings to come in at $5.71 per share, but it turned out to be $6.04, a 5.80% surprise. For the quarter, EBITDA amounted to $2.87 billion. At the end of the quarter ending September 29, Cigna Corporation’s stock balance sheet showed total debt was $32.08 billion. Shareholders own equity worth $305.74 million.

Technical Picture

From a technical analysis perspective, let’s take a brief look at Cigna Corporation (CI) price momentum. RSI 9-day as of the close on 30 December was 51.73%, suggesting the stock is Neutral, with historical volatility in this time frame at 9.10%.

As of today, CI’s price is $332.46 -0.58% or -$1.94 from its 5-day moving average. CI is currently trading +2.44% higher than its 20-day SMA and +16.24% higher than its 100-day SMA. However, the stock’s current price level is +13.05% above the SMA50 and +39.51% above the SMA200.

The stochastic %K and %D were 52.44% and 57.90%, respectively, and the average true range (ATR) was 5.18. With the 14-day stochastic at 52.63% and the average true range at 5.70, the RSI (14) stands at 54.44%. The stock has reached -0.82 on the 9-day MACD Oscillator while the 14-day reading was at -0.99.

Analyst Ratings

The consensus rating for Cigna Corporation (CI) among analysts is Overweight. According to current brokerage recommendations, 0 brokerage firms advise that investors sell CI, while 12 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 3 analysts, while 11 others rate it as a “buy”.

What is CI’s price target for the next 12 months?

Analysts predict a range of price targets between $335.00 and $385.00, with a median target of $360.00. Taking a look at these predictions, the average price target given by analysts for Cigna Corporation (CI) stock is $360.00.


Please enter your comment!
Please enter your name here